All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2005-000086-19 | ''An Open Label Evaluation of Long Term Efficacy and Safety of Posterior Justascleral Injections of Anecortave Acetate 15 mg in Patients with Subfoveal Exudative Age-Related Macular Degeneration (AMD)... | 2008-10-19 | due-trials |
| Reported results | 2005-001179-36 | Efficacy and safety of Dexa-Polyspectran® drops, preserved with benzalkonium chloride, vs. Dexa-Polyspectran® drops without dexamethasone phosphate, preserved with benzalkonium chloride, in patients w... | 2007-06-08 | due-trials |
| Reported results | 2005-001180-65 | Efficacy and safety of Polyspectran® drops, preserved with benzalkonium chloride vs. glycerol ear drops in patients with acute bacterial otitis externa – A double-blind, multicenter, prospective, ran... | 2007-07-06 | due-trials |
| Reported results | 2005-001598-93 | An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study “A”... | 2009-11-13 | due-trials |
| Completed, but no date, and reported results | 2005-001786-34 | Hypotonic efficacy and tollerability of Travoprost in patient with open angle primary glaucoma and/or ocular hypertension, not controlled with dorzolamide + timolol treatment in fixed association, o... | bad-data | |
| Completed, but no date, and reported results | 2005-002252-18 | Hypotonic efficacy and tollerability of Travoprost in patient with glaucoma or ocular hypertension, monotherapy or fixed association beta-blocking not controlled or intollerant. | bad-data | |
| Reported results | 2005-002647-35 | Nepafenac 0.1 Eye Drops, Suspension compared to Ketorolac Trometamol 0.5 Eye Drops, Solution and Placebo Nepafenac Vehicle for the Prevention and Treatment of Ocular Inflammation and Ocular pain a... | 2006-10-03 | due-trials |
| Completed, but no date, and reported results Terminated | 2005-004201-29 | THE EFFICACY AND SAFETY OF TIMOLOL MALEATE 0.5% COMPARED TO BRINZOLAMIDE 1% EACH GIVEN TWICE DAILY WHEN ADDED TO TRAVOPROST 0.004% GIVEN EACH EVENING IN PRIMARY OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENS... | bad-data | |
| Reported results | 2005-004766-16 | Comparison of Safety and Efficacy of Brinzolamide/Timolol Fixed Combination vs COSOPT in Patients with Open-Angle Glaucoma or Ocular Hypertension | 2007-08-30 | due-trials |
| Reported results | 2005-004767-34 | A Six-Week, Multicenter, Randomized, Double-Masked Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of Travoprost 0.004 /Timolol 0.5 Once-Daily Morning Dosing and Once-Daily Evening ... | 2007-05-31 | due-trials |
| Completed, but no date, and reported results | 2005-004768-22 | Clinical study of the mast-cell stabilizing effects of the Olopatadine using the Conjunctival Allergen Challeenge model | bad-data | |
| Completed, but no date, and reported results Terminated | 2006-000071-15 | Study of the Efficacy and Safety of Travatan Therapy compared with Cosopt Therapy in Patients with Open-Angle Glaucoma or Ocular Hypertension. | bad-data | |
| Reported results | 2006-003356-38 | A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of Steroid Induced IOP Elevation | 2009-09-07 | due-trials |
| Completed, but no date, and reported results | 2006-003627-37 | Hypotonic efficacy and tollerability of concomitant supply of Travoprost e Brinzolamide vs dorzolamide-timololo in fixed association in patient with glaucoma or ocular hypertension clinical study, mu... | bad-data | |
| Reported results | 2006-005237-38 | SAFETY AND EFFICACY OF SWITCHING TO THE TRAVOPROST/TIMOLOL MALEATE FIXED COMBINATION (DUOTRAV) FROM PRIOR MONO- OR TWO-DRUG THERAPY IN GERMANY | 2008-12-17 | due-trials |
| Completed, but no date, and reported results | 2007-000515-29 | Adherencia de los pacientes en el uso de Travalert® para la instilación de una combinación fija de travoprost 0.004% / timolol 0.5% comparado con un régimen concomitante de travoprost 0.004% y timolol... | bad-data | |
| Reported results | 2007-002501-45 | Phase IV randomised double masked clinical trial: Assessing morning versus evening dosing of a fixed dose combination of Travoprost 0.004% / Timolol Maleate 0.5% in patients with primary open angle gl... | 2010-10-01 | due-trials |
| Completed, but no date, and reported results | 2007-004212-31 | A Double-Masked, Multiple-Dose, Study of the IOP-Lowering Efficacy of Brinzolamide 1.0% Compared to Placebo When Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy in Prim... | bad-data | |
| Reported results | 2007-005936-99 | Effects of Topical Hypotensive Drugs on Circadian Ocular Perfusion Pressure and Ocular Blood Flow in Patients with Open-Angle Glaucoma | 2012-01-31 | due-trials |
| Completed, but no date, and reported results Terminated | 2008-002750-38 | 24-hour IOP control with Travoprost / Brinzolamide fixed combination once-daily (QD)in the evening vs TRAVATAN | bad-data | |
| Reported results | 2008-002760-34 | A Multi-Center, Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN® in Patients with Open-Angle Glaucoma or Ocular Hypertension | 2009-09-17 | due-trials |
| Reported results | 2008-002780-13 | A Three-Month, Multicenter, Double-Masked Study Comparing the Safety and Efficacy of the Fixed Combination Travoprost + Brinzolamide Eye Drops, Suspension vs Travatan vs Azopt in Patients with Open-An... | 2009-02-17 | due-trials |
| Reported results | 2008-002781-66 | A twelve-month, multicenter, double-masked study of Travoprost / Brinzolamide fixed combination QD AM and Travoprost / Brinzolamide fixed combination QD PM versus COSOPT BID in patients with open-angl... | 2009-01-27 | due-trials |
| Reported results Terminated | 2008-004862-24 | An open-label exploratory study to assess the safety, tolerability and clinical activity of topically applied ESBA105 in patients with acute anterior uveitis | 2010-12-14 | due-trials |
| Reported results | 2008-006027-31 | A Multi-Center Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN in Patients with Open-Angle Glaucoma or Ocular Hypertension | 2010-01-28 | due-trials |
| Reported results | 2008-006718-10 | The Efficacy and Safety of Travoprost 0.004% versus Tafluprost 0.005% in Primary Open-Angle Glaucoma or Ocular Hypertensive Patients. | 2010-03-02 | due-trials |
| Reported results | 2008-007705-37 | The Safety and Efficacy of AL-8309B Ophtalmic Solution for the treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) | 2012-05-31 | due-trials |
| Reported results | 2009-010101-36 | The Efficacy and Safety of Adding the Brinzolamide/Timolol Maleate Fixed Combination (Azarga®) to Prostaglandin Monotherapy | 2010-08-27 | due-trials |
| Reported results | 2009-010536-17 | A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle Following Cataract Surgery in Diabetic Retinopathy Patients | 2011-11-04 | due-trials |
| Reported results | 2009-010604-29 | An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution | 2011-05-18 | due-trials |
| Reported results | 2009-010606-10 | An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using Travoprost APS Eye Drops Solution Versus XALATAN Eye Drops Solution | 2011-05-25 | due-trials |
| Reported results | 2009-010834-23 | A multi-center, double-masked study of the safety and efficacy of DuoTrav APS compared to DuoTrav in patients with open-angle glaucoma or ocular hypertension | 2009-05-01 | due-trials |
| Reported results Terminated | 2009-011036-36 | Estudio multicéntrico de la pigmentación en la red trabecular después de dos años de tratamiento con TRAVATAN 0,004% solución oftálmica. A multicenter study of the pigmentation in the trabecular meshw... | 2012-05-30 | due-trials |
| Reported results | 2009-013178-42 | A Twelve-Month Open-Label Safety Study of Polyquaternium-Preserved DuoTrav APS Dosed Once Daily in Patients with Open-Angle Glaucoma or Ocular Hypertension | 2010-11-01 | due-trials |
| Reported results | 2009-015681-55 | A Dose-Escalation Study of AL-39324 Suspension versus Lucentis™ for the Treatment of Exudative Age-Related Macular Degeneration | 2011-06-20 | due-trials |
| Completed, but no date, and reported results | 2009-015795-10 | Assessing the safety and efficacy of switching to Azarga (Brinzolamide/Timolol Fixed Combination), as replacement therapy in patients with uncontrolled intraocular pressure | bad-data | |
| Reported results | 2009-015796-27 | Patient Preference Comparison of Azarga versus Cosopt, after Single Doses in Patients with Open-Angled Glaucoma or Ocular Hypertension | 2011-05-20 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2009-017319-13 | Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes | 2011-10-14 | bad-data |
| Reported results | 2010-019507-28 | Clinical Evaluation of Nepafenac Ophthalmic Suspension, 0.3% for Prevention and Treatment of Ocular Inflammation and Pain after Cataract Surgery | 2011-05-25 | due-trials |
| Reported results | 2010-021973-35 | Assessing the Safety and Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% Fixed Combination), as Replacement Therapy in Patients Uncontrolled on Bimatoprost 0.03%/Timolol 0.5% Therapy ... | 2011-03-31 | due-trials |
| Reported results | 2010-022948-21 | Efficacy and Safety of Adding the Brinzolamide/Timolol Maleate Fixed Combination (Azarga®) in Ocular Hypertensive or Glaucoma Patients Uncontrolled on Prostaglandin Monotherapy | 2013-04-08 | due-trials |
| Reported results | 2010-024244-15 | "Patient Preference Comparison of Azarga versus Cosopt, in Patients with Open-Angle Glaucoma or Ocular Hypertension." | 2012-10-13 | due-trials |
| Reported results | 2010-024512-34 | Safety and IOP-Lowering Efficacy of Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL Fixed Combination Eye Drops, Suspension compared to Brinzolamide 10 mg/mL Eye Drops, Suspension and Brimonidine 2 mg/mL ... | 2013-01-18 | due-trials |
| Reported results | 2010-024513-31 | Efficacy and Safety of Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL Eye Drops, Suspension Compared to Brinzolamide 10 mg/mL Eye Drops, Suspension plus Brimonidine 2 mg/mL Eye Drops, Solution in Patie... | 2013-01-29 | due-trials |
| Reported results | 2011-000161-13 | Assessing the Efficacy and Tolerability of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination), as Replacement Therapy in Patients Previously on Bimatoprost 0.03%/Timolol ... | 2012-11-19 | due-trials |
| Exempt, with results | 2011-000536-28 | Safety and efficacy study with ESBA1008 versus Lucentis for the treatment of exudative age-related macular degeneration | 2013-03-29 | not-yet-due |
| Reported results | 2011-003816-21 | Multi-Center Study Assessing Efficacy and Tolerability of TRAVATAN Solution without BAK, containing Polyquad Preservative (0.004 travoprost) in Patients Previously on latanoprost 0.005 or bimatopros... | 2013-02-12 | due-trials |
| Reported results Terminated | 2011-003851-20 | A Multicente, Observer-Masked Study of the Safety and Efficacy of MDPF Travoprost, 0.004% Compared to TRAVATAN in Patients with Open-Angle Glaucoma or Ocular Hypertension | 2012-02-02 | due-trials |
| Reported results | 2011-004587-29 | A Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost Ophthalmic Solution, 0.003% Compared to TRAVATAN in Patients with Open-Angle Glaucoma or Ocular Hypertension | 2012-08-28 | due-trials |
| Reported results | 2012-001324-34 | A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients | 2014-03-25 | due-trials |
| Listed as ongoing, but also has a completion date and reported results | 2012-001640-22 | An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients | 2013-07-10 | bad-data |
| Reported results | 2012-002078-30 | Assessing the Efficacy and Tolerability of TRAVATAN® Solution without BAK, containing Polyquad® Preservative (travoprost 0.004%) versus LUMIGAN® 0.01% Solution with BAK (bimatoprost 0.01%) in Treatme... | 2014-06-18 | due-trials |
| Reported results | 2013-001874-12 | Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjec... | 2015-05-28 | due-trials |
| Reported results | 2013-005464-25 | Assessment of Anatomical and Functional Outcomes in Patients Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA) | 2015-09-02 | due-trials |
| Completed, but no date Terminated | 2014-004778-41 | Assessment of Anatomical and Functional Outcomes in Subjects Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA) | bad-data | |
| Reported results | 2014-004886-26 | A Two-Year, Randomized, Double-Masked, Multicenter, Two-Arm Study Comparing the Efficacy and Safety of RTH258 6mg Versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration | 2018-03-08 | due-trials |
| Reported results | 2015-000736-15 | Additive Effect of Twice Daily Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue | 2018-02-27 | due-trials |
| Reported results | 2016-000176-20 | Safety and Efficacy with Twice Daily Brinzolamide 1% / Brimonidine 0.2% (SIMBRINZA) as an Adjunctive Therapy to Travoprost 0.004% / Timolol 0.5% (DUOTRAV) | 2018-07-31 | due-trials |
| Trial is outside EEC, and reported results | 2016-004317-27 | A Comparative Study of Olopatadine Hydrochloride Ophthalmic Solution 0.2% QD vs Olopatadine Hydrochloride Ophthalmic Solution 0.1% BID in the Treatment of Allergic Conjunctivitis in Chinese Subjects | bad-data | |
| Trial is outside EEC, and reported results | 2017-002689-30 | Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes | bad-data | |
| Trial is outside EEC, and reported results | 2017-002726-20 | Safety of PATANASE® Nasal Spray in Patients With Perennial Allergic Rhinitis | bad-data | |
| Trial is outside EEC, and reported results | 2017-002727-24 | An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients | bad-data | |
| Trial is outside EEC, and reported results | 2017-002728-26 | A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of olopatadine hydrochloride (AL-4943A) Ophthalmic Solution 0.77% Administered Once Daily | bad-data | |
| Trial is outside EEC, and reported results | 2017-002729-39 | An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in the USA | bad-data | |
| Trial is outside EEC, and reported results | 2017-002730-23 | An Evaluation of the Safety and Efficacy of Moxifloxacin AF Ophthalmic Solution 0.5% for the Treatment of Bacterial Conjunctivitis in the USA | bad-data | |
| Trial is outside EEC, and reported results | 2017-002732-17 | An evaluation of Moxidex Ophthalmic Solution for the treatment of marginal corneal infiltrates. | bad-data | |
| Trial is outside EEC, and reported results | 2017-003841-39 | Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Paediatric Patients | bad-data | |
| Trial is outside EEC, and reported results | 2017-003846-26 | Safety Study of Olopatadine Nasal Spray | bad-data | |
| Trial is outside EEC, and reported results | 2017-003856-22 | Safety and Efficacy of Olopatadine Hydrochloride Nasal Spray in 6-11 Year old Patients. | bad-data | |
| Trial is outside EEC, and reported results | 2017-003953-41 | An Open-label, Long-term Study, with AL-4943A Ophthalmic Solution, 0.2% in Patients with Allergic Conjunctivitis | bad-data | |
| Trial is outside EEC, and reported results | 2017-003970-16 | Safety and Pharmacokinetics of PATANASE in Paediatric Patients 2 to < 6 Years of Age with a history of allergic rhinitis | bad-data | |
| Trial is outside EEC, and reported results | 2018-000615-25 | Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Externa | bad-data | |
| Trial is outside EEC, and reported results | 2018-000640-26 | Safety and Efficacy Evaluation of Topical Moxidex Otic Solution Compared to Moxifloxacin Solution in the Treatment of Acute Otitis Media with Otorrhea through Tympanostomy Tubes (AOMT) | bad-data | |
| Trial is outside EEC, and reported results | 2018-000641-39 | Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Externa (AOE) | bad-data | |
| Trial is outside EEC, and reported results | 2018-000642-19 | Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Peri-Operative Tube Otorrhea | bad-data | |
| Trial is outside EEC, and reported results | 2018-000643-37 | Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes | bad-data |